Veridan Wealth’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$261K Buy
283
+21
+8% +$21.3K 0.1% 73
2025
Q4
$281K Buy
+262
New +$251K 0.09% 70
2025
Q1
$234K Buy
283
+6
+2% +$4.99K 0.11% 71
2024
Q4
$224K Buy
+277
New +$229K 0.11% 81
2024
Q2
$227K Buy
+291
New +$233K 0.09% 79

Other funds holding LLY

Veridan Wealth's LLY Position: Q1 2026 in Review

Veridan Wealth increased its Eli Lilly (LLY) stake by 8% in Q1 2026, buying an estimated $21.3K and bringing the position to 283 shares worth $261K. The position accounts for 0.1% of the portfolio, ranked #73.

Veridan Wealth first reported a position in LLY in Q2 2024 and has held it in 5 quarters since. The position peaked at $281K in Q4 2025. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Veridan Wealth held 283 shares of Eli Lilly worth $261K as of Q1 2026.
  • Veridan Wealth bought 21 Eli Lilly shares in Q1 2026, an estimated $21.3K.
  • Eli Lilly made up 0.1% of Veridan Wealth's portfolio in Q1 2026, its #73 holding.
  • Veridan Wealth first reported a position in Eli Lilly in Q2 2024 and has held it in 5 quarters since.
  • Veridan Wealth's Eli Lilly position peaked at $281K in Q4 2025.
  • 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Veridan Wealth's 13F filing for Q1 2026, filed 15 May 2026.